FLT3 Tyrosine Kinase Domain Point Mutation
1 clinical trials · Condition
◉ Watch FLT3 Tyrosine Kinase Domain Point Mutation
| Record | Firm | Date |
|---|---|---|
| Midostaurin and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia and FLT3 Mutation (NCT02634827) | Mayo Clinic | 2015-12-30 |
Track FLT3 Tyrosine Kinase Domain Point Mutation automatically
Every clearance here is in the API, with alerts when new ones post.